CONFERENCE ON STEROID HORMONES AND BREAST CANCER

类固醇激素与乳腺癌会议

• 批准号: 3654124
• 负责人: GARY ELLIS
• 金额: $ 1.59万
• 依托单位: NATIONAL ACADEMY OF SCIENCES
• 依托单位国家: 美国
• 财政年份: 1989
• 资助国家: 美国
• 起止时间: 1989-09-30 至 1991-09-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3654124
• 关键词: breast neoplasms; epidemiology; female antifertility drug; hormone related neoplasm /cancer; meeting /conference /symposium; steroid hormone

The purpose of this contract is to provide a report on oral contraceptives and breast cancer to the NICHD which will assist the Institute in its planning for future research as well as provide information on this issue to researchers and clinicians. The Institute of Medicine, National Academy of Sciences shall complete the following tasks: 1. Establish a panel of experts, provide panel members with background information on the relationship between oral contraceptives and breast cancer, and then convene the panel to determine the issues concerning oral contraceptives and breast cancer that need to be considered, reviewed and examined. The panel is to be comprised of approximately 10-15 members which may include but not necessarily be limited to experts in epidemiology, biology, gynecology, pathology, risk assessment, oncology and family planning. 2. Solicit a series of papers from national and international sources on various aspects of steroid hormones and breast cancer which could include: the accumulated epidemiologic literature; in vitro studies; human biologic markers for new in vivo studies; potential modifications of the design of epidemiologic studies to incorporate more fully the emerging concepts from biological and oncological research; implications for clinical practice and public information regarding oral contraceptives. 3. Hold a public meeting at which the solicited scientific papers will be presented. 4. Reconvene the panel of experts to discuss the solicited papers and the results of the public meeting, as well as other available information. Review the advantages and disadvantages of various policy options for oral contraceptives in the United States. 5. Prepare a report on the panel's review of policy options and its suggestions for future research and recommendations for practicing physicians. The report also shall contain the proceedings of the public meeting.

本合同的目的是提供一份关于口服避孕药的报告 和乳腺癌的NICHD将协助研究所在其 规划未来的研究，并提供有关这一问题的信息 to researchers研究人员and clinicians临床医生. 国家科学院医学研究所应完成 以下任务： 1. 设立专家小组，向小组成员提供背景资料 关于口服避孕药与乳腺癌之间关系的信息 癌症，然后召开小组会议，以确定有关口腔问题 避孕药和乳腺癌，需要考虑，审查， 考察 该小组将由大约10-15名成员组成 其中可能包括但不一定限于以下方面的专家： 流行病学、生物学、妇科学、病理学、风险评估、肿瘤学 和计划生育。 2. 从国家和国际来源征集一系列关于以下问题的论文： 类固醇激素和乳腺癌的各个方面，其中可能包括： 累积的流行病学文献;体外研究;人体生物学 新体内研究的标记物; 流行病学研究，以更充分地纳入新出现的概念， 生物学和肿瘤学研究;临床实践的意义 以及关于口服避孕药的公共信息。 3. 举行一次公开会议，在会上征求的科学论文将被 提出了 4. 重新召集专家小组，讨论征求的文件和 公开会议的结果以及其他现有资料。 审查各种政策选择的利弊， 避孕药在美国 5. 编写一份关于小组审查政策选择及其 对未来研究和实践的建议 医生 该报告还应包括公众的诉讼程序 会议